PMID- 18193443 OWN - NLM STAT- MEDLINE DCOM- 20090106 LR - 20181113 IS - 0937-4477 (Print) IS - 1434-4726 (Electronic) IS - 0937-4477 (Linking) VI - 265 Suppl 1 IP - Suppl 1 DP - 2008 Jul TI - Short-fragment PCR assay for highly sensitive broad-spectrum detection of human papillomaviruses in laryngeal squamous cell carcinoma and normal mucosa: clinico-pathological evaluation. PG - S89-96 LID - 10.1007/s00405-007-0569-5 [doi] AB - The aim of the study was to determine the prevalence and genotypes of HPV infection in laryngeal cancer specimens, normal mucosa obtained from the surgical margin and laryngeal nodules using a novel high sensitive and specific SPF(10) HPV DNA test, PCR/DEIA method and INNO-LiPA genotyping assay. The correlation between HPV presence and clinico-pathological features was analyzed. Tissue samples were collected from 93 primary laryngeal squamous cell carcinoma (LSCC), 49 specimens of normal mucosa and from 22 specimens of laryngeal nodules serving as control group. HPV DNA was amplified by the short PCR fragment (SPF(10)) primer set using HPV DNA enzyme immunoassay (DNA/DEIA) method and INNO-LiPA HPV genotyping assay. Human papillomavirus was detected in 33 (35.5%) of the 93 samples from LSCC, in 4 (8.2%) of 49 samples of the normal mucosa and it was not detected in any of the sample from the control group. Twenty-eight of 33 (81.8%) were positive for HPV-16, 6 of 33 (18.2%) were positive for HPV-18 and 5 of 33 (15.1%) were positive for HPV-33. Multiple infection was found in 5 of 33 (15.1%); 3 samples were positive for HPV-16 and HPV-33, 2 samples for HPV-16 and HPV-18. There was a statistically significant correlation between the presence of HPV in LSCC tumors and in control group samples and between the presence of HPV in the tumors and normal mucosa from the free surgical margin. The presence of HPV infection in 35.5% of the cases suggests a possible role in the etiology of laryngeal cancer and supports the role of high-risk types of HPV (16, 18 and 33) in LSCC. HPV infection is not likely to influence survival rates as an independent prognostic factor in patients with laryngeal cancer. FAU - Morshed, Kamal AU - Morshed K AD - Department of Otolaryngology Head and Neck Surgery, Medical University of Lublin, ul. Jaczewskiego 8, 20-954 Lublin, Poland. kamal1@op.pl FAU - Polz-Dacewicz, Malgorzata AU - Polz-Dacewicz M FAU - Szymanski, Marcin AU - Szymanski M FAU - Polz, Dorota AU - Polz D LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20080105 PL - Germany TA - Eur Arch Otorhinolaryngol JT - European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery JID - 9002937 RN - 0 (DNA, Viral) SB - IM MH - Alphapapillomavirus/genetics/*isolation & purification MH - Carcinoma, Squamous Cell/pathology/*virology MH - DNA, Viral/isolation & purification MH - Electrophoresis, Agar Gel MH - Human papillomavirus 16/isolation & purification MH - Human papillomavirus 18/isolation & purification MH - Humans MH - Laryngeal Neoplasms/*virology MH - Larynx MH - Papillomavirus Infections/*complications MH - Paraffin Embedding MH - Polymerase Chain Reaction/*methods MH - Sensitivity and Specificity PMC - PMC2441493 EDAT- 2008/01/15 09:00 MHDA- 2009/01/07 09:00 PMCR- 2008/06/27 CRDT- 2008/01/15 09:00 PHST- 2007/10/07 00:00 [received] PHST- 2007/12/20 00:00 [accepted] PHST- 2008/01/15 09:00 [pubmed] PHST- 2009/01/07 09:00 [medline] PHST- 2008/01/15 09:00 [entrez] PHST- 2008/06/27 00:00 [pmc-release] AID - 569 [pii] AID - 10.1007/s00405-007-0569-5 [doi] PST - ppublish SO - Eur Arch Otorhinolaryngol. 2008 Jul;265 Suppl 1(Suppl 1):S89-96. doi: 10.1007/s00405-007-0569-5. Epub 2008 Jan 5.